Cargando…
Serum Level and Activity of Butylcholinesterase: A Biomarker for Post-Stroke Dementia
Cholinergic neurotransmission regulates the immune response and inhibits cytokine release after stroke. The changes in the level/activity of blood cholinesterase (ChE) in patients with post-stroke dementia (PSD) are less known. This study aimed to examine post-stroke plasma acetylcholinesterase (ACh...
Autores principales: | Chen, Yi-Chun, Chou, Wen-Hai, Fang, Chiu-Ping, Liu, Tung-Hsia, Tsou, Hsiao-Hui, Wang, Yun, Liu, Yu-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912582/ https://www.ncbi.nlm.nih.gov/pubmed/31653081 http://dx.doi.org/10.3390/jcm8111778 |
Ejemplares similares
-
Refocusing SIDS research: Is butylcholinesterase a predictive biomarker?
por: Matthews, Emma
Publicado: (2022) -
A Post-hoc Study of D-Amino Acid Oxidase in Blood as an Indicator of Post-stroke Dementia
por: Chen, Yi-Chun, et al.
Publicado: (2019) -
Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine
por: Liu, Tung-Hsia, et al.
Publicado: (2017) -
Chinese Medicine Patterns in Patients with Post-Stroke Dementia
por: Tang, Nou-Ying, et al.
Publicado: (2012) -
Splice-Site Variants in the Gene Encoding GABA-A Receptor Delta Subunit Are Associated with Amphetamine Use in Patients under Methadone Maintenance Treatment
por: Lin, Yen-Feng, et al.
Publicado: (2022)